How to choose your reconstitution volume Your choice depends on where you are in the dosing protocol
These drugs have been hailed as breakthroughs, but their effects on human health, including the eyes, tell a more complicated story
October 2023: A Significant Shift in FAA Policy In September and October 2023, the FAA introduced major changes that streamlined medical certification protocol and expanded eligibility for certain weight loss medications, including GLP-1 receptor agonists such as: Semaglutide (Wegovy) Liraglutide (Saxenda) Tirzepatide (Zepbound, Mounjaro) Rather than issuing blanket prohibitions, the FAA established specific pathways for certification (including a fast-track), observation periods, documentation requirements and ongoing monitoring
2014;147:12161218 el Aggan HA, el-Aggan HA, Abou Seif Helmy M, Guirguis TG
Use of GLP-1 medications may reduce the efficacy of oral hormonal contraceptives (birth control)